Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3019580 | Revista Española de Cardiología Suplementos | 2009 | 14 Pages |
Abstract
In the course of the last year, a number of important clinical trials on cardiovascular disease, principally in hypertensive and diabetic patients, have published their results. The findings, some of which were unexpected, have enabled us, in certain instances, to confirm what already we knew about controlling these risk factors, but they have also led to active discussion about well-established topics, such as: To what extent should blood pressure and glycemia levels be reduced in patients with cardiovascular disease? In addition, up-to-date information has become available about treating hypertension with new drugs or new combinations of existing drugs. This article contains a review of all these topics and also summarizes the findings of some observational studies carried out by the working group on hypertension of the Spanish Society of Cardiology that have been reported in the last year.
Keywords
IECAantagonistas del receptor de la angiotensina IISRAAARA-IIEVPITBACVHbA1cHVIHTAVascular damageEnfermedad vascular periféricaprevención cardiovascularCardiovascular preventionantihypertensive treatmentTratamiento antihipertensivoSíndrome metabólicoAccidente cerebrovascularSistema renina-angiotensina-aldosteronaíndice tobillo-brazoPresión arterialHipertensión arterialpresión arterial diastólicapresión arterial sistólicaInhibidores de la enzima de conversión de angiotensinaPASHipertrofia ventricular izquierdaPADGlycemic controlControl glucémicoGlucohemoglobina
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pilar Mazón-Ramos, Alberto Cordero-Fort, Juan Quiles-Granado, Josep Guindo-Soldevila,